Characterization of the nasopharyngeal microbiome in patients with Kawasaki disease.
Corynebacterium
Kawasaki
Microbioma
Microbioma respiratorio
Microbiome
Respiratory microbiome
Journal
Anales de pediatria
ISSN: 2341-2879
Titre abrégé: An Pediatr (Engl Ed)
Pays: Spain
ID NLM: 101765626
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
16
07
2021
accepted:
16
11
2021
pubmed:
15
10
2022
medline:
9
11
2022
entrez:
14
10
2022
Statut:
ppublish
Résumé
The aetiology of Kawasaki disease (KD) remains unknown. Several studies have linked the human microbiome with some diseases. However, there are limited studies on the role of the respiratory microbiome in KD. The aim of our study was to make a more thorough analysis of the causes and processes that increase the susceptibility to KD. Case-control study comparing the respiratory microbiome of KD patients with that of healthy children. The V3-V4 region of the 16S rRNA bacterial gene and 16 respiratory viruses were analysed by real-time polimerase-chain reaction. We used the Ribosomal Database Project (RDP) version 11.5 (taxonomic assignment). The initial sample included 11 cases and 11 controls matched for age, sex and seasonality. One of the cases was excluded to poor sample quality. The final analysis included 10 cases and 10 controls. In the case group, the analysis detected Haemophilus, Moraxella, Streptococcus and Corynebacterium species (27.62%, 19.71%, 25.28%, 11.86%, respectively). In the control group, it found Haemophilus, Streptococcus, Moraxella, and Dolosigranulum species (38.59%, 23.71%, 16.08, 8.93%, respectively). We found a higher relative abundance of Corynebacterium in patients with KD (11.86% vs. 1.55%; P = 0.004). To our knowledge, this is the first study that has found differences in the composition of the respiratory microbiome between patients with KD and healthy controls. The relative abundance of Corynebacterium spp. was greater in the KD group. This study shows differences in the microbiome between cases and controls, which suggests that the microbiome may play a role in facilitating the development of KD.
Identifiants
pubmed: 36241544
pii: S2341-2879(22)00176-4
doi: 10.1016/j.anpede.2022.08.001
pii:
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
300-309Informations de copyright
Copyright © 2022 Asociación Española de Pediatría. Published by Elsevier España, S.L.U. All rights reserved.